Saw Palmetto Claims Appeal Shot Down; Emord Eyes Supreme Court

The Washington, D.C. federal appeals court upheld FDA's denial of a health claim petition linking saw palmetto extract to treatment of benign prostatic hypertrophy

More from Archive

More from Pink Sheet